“We reiterate our expectation of positive Adj. EBITDA for the full fourth quarter of 2026, with 2027 expected to be our first full year of Adj. EBITDA profitability; we first noted these expectations in 2022, underscoring the predictability of our model and a consistent record of execution.”
Said Feb 19, 2026Deadline Dec 31, 2027Lemonade Q4 2025 shareholder letter and earnings call (SEC Form 8-K), February 19, 2026; reiterated on the Q2 2026 earnings call
Q4 2026 has not yet been reported; on the Q2 2026 call management reiterated the target (implied Q4 2026 adjusted EBITDA of roughly $8 million) and credited AI-driven claims automation for a record-low 5% LAE ratio versus an industry average of about 9%. Full resolution requires FY2027 results.